open access

Vol 19, No 2 (2013)
Case reports
Published online: 2013-07-10
Get Citation

Decreased plasma concentrations of a-ketoglutarate in patients with chronic symptomatic coronary heart disease compared with healthy controls

Magdalena Stachura, Per Gustavsson, Stefan G. Pierzynowski, Jacek Wroński
Acta Angiologica 2013;19(2):82-92.

open access

Vol 19, No 2 (2013)
Case reports
Published online: 2013-07-10

Abstract

BACKGROUND: Recent studies revealed that mitochondrial function is altered since the earliest stages of atherosclerosis development. Experimental studies results revealed that endothelial dysfunction, elevated levels of inflammatory cytokines, such as excessive reactive oxygen species production, which underlie atherosclerosis, result in significant disruptions in the Krebs cycle flux. However, there is little data about the influence of atherosclerosis on the Krebs cycle intermediates concentrations in people. The aim of the study was to evaluate a possible influence of chronic cardiac ischemia on plasma concentrations of a-ketoglutarate in people with stable symptomatic coronary heart disease.

MATERIAL AND METHODS: Blood samples were collected from 53 patients, with stable, symptomatic coronary heart disease confirmed in coronarography, who were admitted to the hospital due to persistent severe angina despite pharmacological treatment, without the elevation of cardiac enzymes blood level. The control group included 20 healthy people. Plasma concentrations of a-ketoglutarate were determined using an high-performance liquid chromatography (HPLC).

RESULTS: Patients with stable coronary heart disease had significantly lower a-ketoglutarate plasma concentrations compared to healthy controls. There were no statistically significant differences in other analyzed clinical and biochemical parameters between both groups.

CONCLUSIONS: 1. Patients with chronic myocardial ischemia have lower plasma concentrations of a-ketoglutarate comparing to healthy controls. 2. The decrease of plasma a-ketoglutarate concentrations in these patients may be a consequence of the Krebs cycle disruption due to the influence of endothelial dysfunction and inflammatory processes involved in the development of atherosclerosis, however further investigations are required.

Abstract

BACKGROUND: Recent studies revealed that mitochondrial function is altered since the earliest stages of atherosclerosis development. Experimental studies results revealed that endothelial dysfunction, elevated levels of inflammatory cytokines, such as excessive reactive oxygen species production, which underlie atherosclerosis, result in significant disruptions in the Krebs cycle flux. However, there is little data about the influence of atherosclerosis on the Krebs cycle intermediates concentrations in people. The aim of the study was to evaluate a possible influence of chronic cardiac ischemia on plasma concentrations of a-ketoglutarate in people with stable symptomatic coronary heart disease.

MATERIAL AND METHODS: Blood samples were collected from 53 patients, with stable, symptomatic coronary heart disease confirmed in coronarography, who were admitted to the hospital due to persistent severe angina despite pharmacological treatment, without the elevation of cardiac enzymes blood level. The control group included 20 healthy people. Plasma concentrations of a-ketoglutarate were determined using an high-performance liquid chromatography (HPLC).

RESULTS: Patients with stable coronary heart disease had significantly lower a-ketoglutarate plasma concentrations compared to healthy controls. There were no statistically significant differences in other analyzed clinical and biochemical parameters between both groups.

CONCLUSIONS: 1. Patients with chronic myocardial ischemia have lower plasma concentrations of a-ketoglutarate comparing to healthy controls. 2. The decrease of plasma a-ketoglutarate concentrations in these patients may be a consequence of the Krebs cycle disruption due to the influence of endothelial dysfunction and inflammatory processes involved in the development of atherosclerosis, however further investigations are required.

Full Text:

View HTML
Get Citation

Keywords

a-ketoglutarate, Krebs cycle, oxidative stress, atherosclerosis

About this article
Title

Decreased plasma concentrations of a-ketoglutarate in patients with chronic symptomatic coronary heart disease compared with healthy controls

Journal

Acta Angiologica

Issue

Vol 19, No 2 (2013)

Pages

82-92

Published online

2013-07-10

Bibliographic record

Acta Angiologica 2013;19(2):82-92.

Keywords

a-ketoglutarate
Krebs cycle
oxidative stress
atherosclerosis

Authors

Magdalena Stachura
Per Gustavsson
Stefan G. Pierzynowski
Jacek Wroński

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl